skip to content

Daniel O'Day

CV as per end of term

Zur deutschen Version

Personal Data

Nationality
American

Year of Birth
1964

CEO Roche Pharmaceuticals

Studies

  • Georgetown University, Washington DC, Bachelor of Science (Biology) (1986)

  • Columbia University, New York, MBA (1997)

Professional Career

1987-1995
Roche Pharma, US, Various commercial/sales roles

1995
Roche Pharma, US, Director Human Resources

1996
Roche Pharma, US, Director Product Marketing

1998
Roche Pharma HQ, Switzerland, Head Business Unit, Arthritis and Respiratory

1999
Roche Pharma HQ, Switzerland, Lifecycle Leader Tamiflu

2001
Roche Pharma, Japan, Head Corporate Planning, Tokyo

2003
Roche Pharma, Denmark, General Manager

2006
Roche Molecular Diagnostics (RMD), Pleasanton, US, President & CEO

2010
Roche Diagnostics Division, Chief Operating Officer and Member of the Roche Corporate Executive Committee

2012
Roche Pharmaceuticals Division, COO and Member of the Roche Corporate Executive Committee

Möchten Sie den Inhalt auf Deutsch lesen?

Zur deutschen Version

About Roche

View all leaders

Discover more

Our approach to sustainability
About Roche

Sustainability is integrated into Roche’s corporate vision, values, operating standards and guidelines. This approach means no single department is responsible for managing sustainability.

Code of conduct
About Roche

The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.

Investors
Investors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.

Board Committees
About Roche

Our Board of Directors has delegated certain matters to four committees for detailed attention.

Executive Committee
About Roche

The Executive Committee's composition and the curricula vitae of its members.

Articles of Incorporation & Bylaws
About Roche

Our Articles of Incorporation contain the principal information on Roche's business purpose, structures and statutory bodies.